# The Pill Project - Oral Contraceptive and Serotonergic Brain Signaling

> **NCT05212389** · NA · UNKNOWN · sponsor: **Rigshospitalet, Denmark** · enrollment: 40 (estimated)

## Conditions studied

- Major Depressive Disorder
- Sexual Behavior
- Mood Disturbance
- Mood Change
- Affect Altered
- Affect Blunted
- Drug Mechanism

## Interventions

- **DRUG:** Femicept
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05212389
- **Lead sponsor:** Rigshospitalet, Denmark
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-12-22
- **Primary completion:** 2024-08-31
- **Final completion:** 2025-08-31
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2022-02-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05212389

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05212389, "The Pill Project - Oral Contraceptive and Serotonergic Brain Signaling". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05212389. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*